Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

106
Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
106
Types of RNA01:23

Types of RNA

61.3K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
61.3K
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

191
Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
191
Antimicrobial Proteins01:23

Antimicrobial Proteins

10.6K
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
10.6K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

90
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
90
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.2K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ribosome hibernation in zinc-starved <i>Mycobacterium abscessus</i> confers amikacin tolerance.

Microbiology spectrum·2026
Same author

HflX-mediated drug resistance through ribosome splitting and rRNA disordering in mycobacteria.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

What makes <i>Candida auris</i> pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs.

Antimicrobial agents and chemotherapy·2024
Same author

What makes <i>Candida auris</i> pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs.

bioRxiv : the preprint server for biology·2024
Same author

Drug resistance through ribosome splitting and rRNA disordering in mycobacteria.

bioRxiv : the preprint server for biology·2024
Same author

Clinical Course, Antifungal Susceptibility, and Genomic Sequencing of Trichophyton indotineae.

JAMA dermatology·2024

Related Experiment Video

Updated: May 1, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

16.2K

How Medically Important Antimicrobials Bind to the 30S Ribosomal Subunit in a Bacterial Pathogen.

Swati R Manjari1, Caleb Mallery2, Nilesh K Banavali1,2,3

  • 1Laboratory of Cellular and Molecular Basis of Diseases, Division of Genetics, Wadsworth Center, New York State Department of Health, Empire State Plaza, Albany, New York 12237, United States.

Biochemistry
|April 30, 2026
PubMed
Summary
This summary is machine-generated.

Researchers analyzed how medically important antimicrobials (MIAs) bind to bacterial ribosomes. Computational methods predict MIA binding to the Lyme disease bacterium

More Related Videos

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

1.6K
Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
11:19

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

20.5K

Related Experiment Videos

Last Updated: May 1, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection
11:56

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

16.2K
Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

1.6K
Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses
11:19

Isolation of Translating Ribosomes Containing Peptidyl-tRNAs for Functional and Structural Analyses

Published on: February 25, 2011

20.5K

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Structural Biology

Background:

  • Ribosomes synthesize proteins by translating mRNA, with decoding occurring in the small subunit.
  • Medically important antimicrobials (MIAs) like aminoglycosides and tetracyclines target bacterial ribosome decoding centers, causing protein synthesis errors.
  • High-resolution structures reveal MIA binding to bacterial ribosomal small subunits, crucial for understanding antibiotic action.

Purpose of the Study:

  • To comprehensively analyze existing structures of medically important antimicrobials (MIAs) bound to bacterial ribosomal small subunits.
  • To understand the variability in how MIAs bind to these subunits.
  • To develop computational methods for predicting MIA binding to the 30S small subunit of *Borrelia burgdorferi* (Bbu) ribosomes.

Main Methods:

  • Comprehensive analysis of previously reported high-resolution structures of MIAs bound to bacterial ribosomes.
  • Utilizing structural analogy, restrained energy minimization, and single-point binding free energy computations.
  • Applying these methods to predict MIA binding to the *Bbu* ribosomal 30S small subunit.

Main Results:

  • The binding free energy of MIAs is highly sensitive to minor conformational changes in the MIA and its surrounding environment.
  • Computational methods, including structural analogy and energy minimization, can predict MIA binding to the *Bbu* 30S ribosomal subunit.
  • Variability in MIA binding modes to bacterial ribosomal small subunits was analyzed.

Conclusions:

  • Understanding MIA binding variability is key for developing targeted antibiotics.
  • Computational predictions of MIA binding can be achieved using structural analysis and energy computations.
  • Structure-guided design incorporating binding sensitivity can lead to narrow-spectrum MIAs for specific bacterial pathogens like *Bbu*.